Literature DB >> 16520204

Blood rheology in PCA and PCEA after total knee arthroplasty.

Benzion Beilin1, Eduard Mayburd, Israel-Zeev Yardeni, David Hendel, Dror Robinson, Hanna Bessler.   

Abstract

The rheological events in 2 groups of patients undergoing total knee arthroplasty were compared--15 patients were given general anesthesia and controlled their postoperative pain applying intravenous patient-controlled analgesia; 17 individuals received combined spinal-epidural anesthesia and controlled their postoperative pain by patient-controlled epidural analgesia (PCEA). Twenty-four and 48 hours after surgery, the patient-controlled analgesia group showed a significant increase in whole-blood viscosity at the 3 shear rates (P < .01), as well as in relative viscosity at both periods (P < .001 and .01, respectively). Similar findings were observed for red blood cell aggregation (P < .001) and fibrinogen level (P < .001). These values were less expressed in the PCEA group, particularly 48 hours after surgery (P < .01), and the patients showed lower scores on the visual analog pain scale. The better results observed in the PCEA group favor the application of epidural anesthesia and PCEA analgesia in patients undergoing total knee arthroplasty.

Entities:  

Mesh:

Year:  2006        PMID: 16520204     DOI: 10.1016/j.arth.2005.04.038

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  2 in total

1.  The Use of Opioids and Pain Medications in the Management of Postoperative Pain in Total Knee Arthroplasty Patients: A Retrospective Study.

Authors:  Ammar Almustafa; Asdghig Der-Boghossian; Abdel Majid Sheikh Taha
Journal:  Pain Res Manag       Date:  2022-03-29       Impact factor: 3.037

2.  Comparing effects of low and high-flow anesthesia on hemorheology and coagulation factors.

Authors:  Orhan Binici; Ismail Kati; Ugur Goktas; Lokman Soyaral; Osman Cagatay Aytekin
Journal:  Pak J Med Sci       Date:  2015       Impact factor: 1.088

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.